Effects of Cariprazine on Cardiac Repolarization in Patients With Schizophrenia

Completed · Phase 1 · Has a placebo group

Conditions studied: Schizophrenia

In brief

This study will evaluate the effects of sequential multiple dose regimens of cariprazine on cardiac repolarization in patients with schizophrenia.

Key facts

Study ID

NCT01376076

Run by

Forest Laboratories

People needed

129

Starts

2011-06-01

Expected to finish

2012-02-01

Last updated by the study team

2012-02-08

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Men or women, age 18 to 50, inclusive
• Symptoms of schizophrenia or schizoaffective disorder first appearing a minimum of 1 year before screening
• Negative pregnancy test
• Normal physical examination results, vital signs, and clinical lab test results

You may not qualify if…

• Axis II disorder severe enough to interfere with the study
• Smoking more than 20 cigarettes a day
• History or presence of cardiovascular disorder
• Pregnant/breast-feeding and/or planning to become pregnant/breast-feed
• Imminent risk of injuring self or others or causing significant property damage

Where it is running

• Forest Investigative Site 001 — Glendale, California, United States
• Forest Investigative Site 004 — Long Beach, California, United States
• Forest Investigative Site 002 — Willingboro, New Jersey, United States
• Forest Investigative Site 003 — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.